| 14.9.74
|
CVA Reading 1, p.37, pl. 22, no.27; Lemos 1991 p.241, no.230; Villing et al 2013-2015
(ORC) GD.0246 phase 2;
|
|
| 26.2.54
|
Lemos 1991 p.315, no.1353; CVA ReadingI, p.37, pl.22, no.28; Villing et al 2013-2015 (ORC) GD.2118, phase 2;
|
|
| 26.2.55
|
CVA Reading 1, p.37, pl.22, no.29; Villing et al 2013-2015 (ORC) GF.154;
|
|
| 26.2.58
|
CVA Reading p.37, pl.22, no.26; Villing et al 2013-2015 (ORC) GG.400;
|
|
| 26.2.59
|
CVA Reading 1, p.37, pl.23., no.1a-b; Villing et al 2013-2015 (ORC) GD.0848 phase 2;
|
|
| 26.2.60
|
CVA Reading 1, p.37, pl.23, no.2a-b; Lemos 1991 p.303, no.1113, pl.153; Villing et al 2013-2015 (ORC) GD.0866 phase 2;
|
|
| 26.2.61
|
CVA Reading 1, p.37, pl.23, no.3a-b; Villing et al 2013-2015 (ORC) GD.1522 phase 2; Lemos 1991 p.303, no.1115, pl.153;
|
|
| 26.2.62
|
CVA Reading 1, p.37, pl.23, no.4a-b; Lemos 1991 p.292, no.912, pl.121; Villing et al (2013-2015) ORC GD.1214 phase 2;
|
|
| 26.2.66
|
CVA Reading 1, p.37, pl.23, no.8; Lemos 1991 p.306, no.1225, pl.159; Villing et al 2013-2015 (ORC) GD.2025 phase 2;
|
|
| 26.2.67
|
CVA Reading 1, p.37, pl.23, no.9a-b; Lemos 1991 p. 303, no.1114, pl.153; Villing et al 2013-2015 (ORC) GD.0668 phase 2;
|
|